Monday, 27 May 2019

BioServices News

  • BSA-CMR Survey: New CRO players emerge in APAC

    BioServices |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • ImmusanT starts trials of celiac disease vaccine, Nexvax2

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 05 Sep, 2012

    Singapore: ImmusanT initiated clinical trials in New Zealand, Australia and the US to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed...Read more

  • Quintiles signs bioanalytical deal with Korean CRO

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 20 Dec, 2012

    Singapore: To enhance its bioanalytical service offerings in Asia, Quintiles has signed an exclusive partnership with BioCore, a leading Seoul-based bioanalytical contract research organiza...Read more

  • SymBio Pharma completes patient enrollment

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial of Treakisym (bendamustine hydrochloride, SyB L-0501) in frontline low...Read more

  • Challenge No 10: Lack of mid-size CROs

    BioServices |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    For the CRO industry, the biggest challenge will be to develop a credible mid-sized offering to the industry. Currently, this does not exist. (Read about all 10 challenges for businesses in...Read more

  • Vedic's health study on men is a success

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 30 Nov, 2012

    Singapore: Vedic Lifesciences has successfully completed four human studies on sexual health, for various clients from Canada and India. Research papers for two of these studies have been p...Read more

  • Telstar to set up plants for Square in Bangladesh

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

    Singapore: Telstar, a provides of life sciences solutions headquartered in Spain, will set up two new pharmaceutical plants for the Bangladesh-based firm Square Pharmaceuticals. Square is t...Read more

  • Temptime expands business in Asia

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 01 Jun, 2012

    Singapore: Temptime, the world leader in time temperature indicators, has opened a business office in Beijing, China, marking a significant advancement in their global effort to improve dis...Read more

  • INC Research opens two new offices in Japan

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, announced the establishment of INC ...Read more

  • FDA raps Chinese clinical trials for 'sloppy data'

    BioServices |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: China offers a cheaper and bigger market for clinical trials, but its sloppy data generation and irregularities in clinical trial procedures has drawn the ire of the US regulator...Read more

  • AusBiotech advocates strong clinical trial program

    BioServices |  Analysis | By BioSpectrum Bureau  | 0 Comment | 25 May, 2012

    Singapore: Australia, which celebrated International Clinical Trials Day on May 20, is looking to strengthen its clinical trials industry. AusBiotech, the bioscience industry association of...Read more

  • New Zealand aims at early phase and proof of concept trials

    BioServices |  Analysis | By Piyusha Chatterjee | 0 Comment | 12 Sep, 2013

    New Zealand has held a clean track record with early phase and proof of concept trials and has maintained accuracy in the compilation of clinical data. The straightforward regulatory system...Read more

  • Mr Tarun Pandotra, PRA India: Drug discovery outsourcing will gain momentum in 2013

    BioServices |  Opinion | By BioSpectrum Bureau  | 0 Comment | 25 Dec, 2012

    The drug discovery outsourcing market will experience high revenue growth from 2013-to-2023. Expansion of the market will be stimulated by the rising costs of pharma R&D, advancing tech...Read more

  • Axway helps Sanofi to 'fool-proof' its IT infrastructure

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2013

    Singapore: Sanofi joined hands with Axway in order to streamline processes and transform its technology infrastructure into an efficient global network. Axway will help the life science gia...Read more

  • Temasek to divest in Medreich Pharma

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 03 Dec, 2012

    Bangalore: Temasek, a Singapore-based investment company with 11 affiliates and offices in Asia and Latin America, is looking to offload its stake in Bangalore-based Medreich Pharma. Temas...Read more

  • Boston Healthcare expands in Asia

    BioServices |  News | By BioSpectrum Bureau  | 0 Comment | 27 Nov, 2012

    Singapore: Boston Healthcare is expanding its health economics, pricing, and reimbursement consulting services with the formation of a strategic advisory practice in Asia. This enhanced pre...Read more

  • Quality researchers give an edge to Australia

    BioServices |  Opinion | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2013

    Australia, known for providing rigorous high quality clinical research and enthusiastic investigators with centers of excellence leading to high quality clinical outcomes, has been acknow...Read more

  • WuXi reports 28.9% growth in Q2 2012

    BioServices |  Company results | By BioSpectrum Bureau  | 0 Comment | 14 Aug, 2012

    Singapore: WuXi PharmaTech, a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the...Read more



Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls